NewsBenzingaNeedham bekräftigt „Buy“ für Harmony Biosciences Hldgs und bestätigt Kursziel von 50 $ Needham bekräftigt „Buy“ für Harmony Biosciences Hldgs und bestätigt Kursziel von 50 $ Benzinga 2026.10.12 13:27 (GMT+0) Open on Benzinga Other news If Apple Cuts iPhone Units in 2027, This Stock Could Be a Big Loser Trust company AnchorWatch Trust Company launches Bitcoin custody service Wells Fargo Maintains Equal-Weight on PENN Entertainment, Lowers Price Target to $22 HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target Alphabet Stock Rises: What's Going On? $1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
